semaglutide tirzepatide compound Troubling Findings in Study of GLP-1 Compounders Compounded Tirzepatide Injections For Effective

A large 2023 study including people without diabetes who were using GLP-1 agonists for weight loss found that this class of medications may increase the risk of gastrointestinal conditions, such as gastroparesis

Any prescribed compounded medications are based on the medical discretion of a licensed provider following a telehealth consultation and review of the patient's medical history.

Nausea more than doubles

Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by taylor dispersion analysis

Disruption of its function has been shown to have major impacts on mitochondrial integrity and cell survival (McStay et al., 2002